Scientists use nanotech to 'upgrade' TB drugs
A TB medication that harnesses nanotechnology to cut treatment time and eliminate side effects has won a prestigious award.
29 September 2009 | EN
Science and Development Network
News, views and information about science, technology and the developing world
Here is a list of the latest articles
A TB medication that harnesses nanotechnology to cut treatment time and eliminate side effects has won a prestigious award.
29 September 2009 | EN
A new tuberculosis drug found using an old method of drug discovery is the first in 40 years to have proved successful in trials.
Mobile phones that enable remote disease diagnosis have been awarded funds for research and developing world field trials.
China is stepping up its fight against TB using the latest technological innovations in diagnostics and drug delivery.
South Africa's University of KwaZulu-Natal will be home to a new HIV/TB research hub focused on combatting the dual infection.
2 April 2009 | EN
Hanging UV lights in hospital wards could reduce the spread of TB by killing even drug-resistant strains, researchers have found.
A quarter of TB deaths occur in HIV patients, says the WHO — double the previous estimate.
A mixture of two drugs has wiped out extensively drug-resistant TB in the laboratory and clinical trials are planned.
A comparison of different strains of tuberculosis has revealed that they are prone to acquiring drug resistance.
A new survey reveals that China has one of the highest levels of multi-drug resistant tuberculosis in the world.
A rapid tuberculosis test that can detect only one in a hundred cases has highlighted the need for regulation, say diagnostics experts.
The US Institute of Medicine says global health — and health research — should become central to US foreign policy.
Singaporean scientists have identified a gene associated with vulnerability to TB, and find males are more susceptible than females.
Researchers report that a potential tuberculosis vaccine has been shown to reduce rates of the disease in patients with HIV/AIDS.
Researchers in Peru have found that early testing to diagnose multidrug-resistant tuberculosis is best to prevent airborne transmission.
Scientists have recommended the antiretroviral drug efavirenz for patients suffering from both HIV and tuberculosis.
About 60 per cent of the patients with extensively drug-resistant tuberculosis can be cured by combining five different drugs, says a study.
11 August 2008 | ES
Following successful clinical trials of a new tool to diagnose drug-resistant TB, the WHO has endorsed its use in all affected countries.
2 July 2008 | EN
A new funding announcement means that African scientists will be able to mastermind their own medical research projects.
Scientists in Vietnam have discovered that the outcome of tuberculosis infection is influenced by bacterial and host genetics.